Sign up to receive Dana-Farber Spotlight, our email newsletter.View the current issueSubscribe nowUnsubscribe from mailings
Ellen BerlinDirector of Media Relations617email@example.com
Molly McHaleAssociate Director of Media Relations617firstname.lastname@example.org
Dana-Farber has launched an extensive research project into cancer genomics.
John Quackenbush, PhD, commented on a study that showed understanding a tumor's genomic profile is more likely to lead to an effective treatment.
Dr. Koen M. A. Dreijerink participated in a study that suggested the MEN1 mutation is also involved in the formation of breast cancer tumors.
The Dana-Farber Mammography Van and the Blum Family Van travel around the Greater Boston area providing cancer screenings.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: